Prospective randomised study assessing the efficacy of Tocilizumab with synovial analysis in patients with rheumatoid arthritis.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms TOCRA
- 10 Jun 2017 Biomarkers information updated
- 28 Apr 2012 United Kingdom Clinical Research Network reports accrual to date changed from 50% to 100%
- 28 Apr 2012 Planned end date changed from 1 Nov 2009 to 27 Feb 2012 as reported by United Kingdom Clinical Research Network.